Literature DB >> 7625534

Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni.

P G Fallon1, R F Sturrock, A C Niang, M J Doenhoff.   

Abstract

There is a recent report of low efficacy of praziquantel (PZQ) treatment of human schistosomiasis in a new Schistosoma mansoni focus in northern Senegal. Biomphalaria pfeifferi snails with patent infections were collected from the area of the focus and transported to the United Kingdom. Groups of mice were infected with cercariae from this Senegalese isolate, or with laboratory-maintained Kenyan or Puerto Rican isolates. In two separate experiments, PZQ was less effective against the parasite from Senegal than against the two other geographic isolates. The reduced susceptibility of S. mansoni to PZQ in infected human populations has important implications for current schistosomiasis control programs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625534

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  45 in total

Review 1.  Drug resistance in human helminths: current situation and lessons from livestock.

Authors:  S Geerts; B Gryseels
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.

Authors:  Afzal A Siddiqui; Troy Phillips; Hugues Charest; Ron B Podesta; Martha L Quinlin; Justin R Pinkston; Jenny D Lloyd; Michelle Paz; Rachael M Villalovos; Janet Pompa
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

3.  Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice.

Authors:  Hong-jun Li; Wei Wang; Guo-li Qu; You-zi Li; Yong-hui Tao; Yun-tian Xing; Xiao-ting Wang; Yang Dai; Jian-ying Wei; Jian-rong Dai; Gerald C Coles; You-sheng Liang
Journal:  Parasitol Res       Date:  2011-10-18       Impact factor: 2.289

4.  Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni.

Authors:  R Tarrab-Hazdai; D Schechtman; R Arnon
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  In-vivo activity of dihydroartemisinin against Schistosoma japonicum.

Authors:  H-J Li; W Wang; G-L Qu; Y-H Tao; Y-T Xing; Y-Z Li; J-Y Wei; J-R Dai; Y-S Liang
Journal:  Ann Trop Med Parasitol       Date:  2011-03

Review 6.  Susceptibility or resistance of praziquantel in human schistosomiasis: a review.

Authors:  Wei Wang; Li Wang; You-Sheng Liang
Journal:  Parasitol Res       Date:  2012-10-07       Impact factor: 2.289

7.  Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum.

Authors:  Wei Wang; Tian-Yu Li; Yuan Ji; Guo-Li Qu; Yi-Li Qian; Hong-Jun Li; Jian-Rong Dai; You-Sheng Liang
Journal:  Parasitol Res       Date:  2013-12-11       Impact factor: 2.289

8.  Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays.

Authors:  Stephanie Howe; Dorina Zöphel; Harini Subbaraman; Clemens Unger; Jana Held; Thomas Engleitner; Wolfgang H Hoffmann; Andrea Kreidenweiss
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

9.  A 1,536-well-based kinetic HTS assay for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase.

Authors:  Wendy A Lea; Ajit Jadhav; Ganesha Rai; Ahmed A Sayed; Cynthia L Cass; James Inglese; David L Williams; Christopher P Austin; Anton Simeonov
Journal:  Assay Drug Dev Technol       Date:  2008-08       Impact factor: 1.738

10.  Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.

Authors:  Sandra D Melman; Michelle L Steinauer; Charles Cunningham; Laura S Kubatko; Ibrahim N Mwangi; Nirvana Barker Wynn; Martin W Mutuku; Diana M S Karanja; Daniel G Colley; Carla L Black; William Evan Secor; Gerald M Mkoji; Eric S Loker
Journal:  PLoS Negl Trop Dis       Date:  2009-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.